Natco Pharma Ltd
Natco Pharma's GHG Emissions Data Preview
In 2025, Natco Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Natco Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Verified Sources Behind Natco Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Natco Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Natco Pharma's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Natco Pharma amounted to 72,125.3 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Natco Pharma increased by 2.79%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Natco Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Natco Pharma's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Natco Pharma were 28,494.95 metric tons of CO₂ equivalent (tCO₂e). a
Has Natco Pharma reduced its Scope 1 emissions over time?
Since 2021, Natco Pharma's Scope 1 emissions have increased by 114.81%, reflecting a rising long-term trend in Scope 1 emissions over time. a c
Compared to the previous year (2024), Natco Pharma's Scope 1 emissions remained relatively stable, indicating that Natco Pharma's emissions have plateaued with no significant change in its operational footprint. a
What are Natco Pharma's Scope 2 emissions?
In 2025, Natco Pharma reported Scope 2 greenhouse gas (GHG) emissions of 43,630.35 tCO₂e without specifying the calculation method. a
Has Natco Pharma reduced its Scope 2 emissions over time?
Since 2021, Natco Pharma's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Natco Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a c
Compared to the previous year (2024), Natco Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Natco Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Natco Pharma use for Scope 2 reporting?
In 2025, Natco Pharma reported its Scope 2 emissions using an unspecified methodology. a
Natco Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Natco Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Natco Pharma reported Scope 1 greenhouse gas (GHG) emissions of 28,494.95 tCO₂e and total revenues of USD 518 millions. This translates into an emissions intensity of 54.96 tCO₂e per millions USD. a
Natco Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Natco Pharma's GHG emissions intensity compare to its peers?
In 2025, Natco Pharma reported a Scope 1 emissions intensity of 54.96 tCO₂e per millions USD. Compared to the peer group median of 24.05 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Natco Pharma rank on GHG emissions intensity within its industry?
In 2025, Natco Pharma ranked 15 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Natco Pharma is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a